Study of Cabozantinib as Monotherapy or in Combination With Nivolumab in Patients With Advanced or Metastatic Renal Cell Carcinoma Under Real-life Clinical Setting in 1st Line Treatment.
NCT ID: NCT03647878
Last Updated: 2025-12-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
224 participants
OBSERVATIONAL
2018-09-24
2027-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subjects receiving cabozantinib as monotherapy or in combination with nivolumab as a first line treatment for advanced or metastatic renal cell carcinoma
* Subjects with the intention to be treated with cabozantinib tablets as monotherapy or in combination with nivolumab according to the current local Summary of Product Characteristics (SmPC); decision has to be taken before entry in the study.
* Signed written informed consent
Exclusion Criteria
* Previous participation in this study
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ipsen
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ipsen Medical Director
Role: STUDY_DIRECTOR
Ipsen
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Landeskrankenhaus Hochsteiermark
Leoben, , Austria
Kepler Universitätsklinikum GmbH
Linz, , Austria
Uniklinikum Salzburg
Salzburg, , Austria
Salzkammergutklinikum Vöcklabruck
Vöcklabruck, , Austria
Klinikum Wels-Grieskirchen GmbH
Wels, , Austria
Universitätsklinikum Aachen
Aachen, , Germany
Urologisches Zentrum Euregio
Aachen, , Germany
Onkologie aschaffenburg
Aschaffenburg, , Germany
Universitätsklinikum Augsburg A.ö.R
Augsburg, , Germany
MVZ Taunus GmbH
Bad Homburg, , Germany
Hämatologisch-Onkologische Schwerpunktpraxis
Bad Liebenwerda, , Germany
Urologische Praxis Bad Schlema
Bad Schlema, , Germany
Klinikum am Bruderwald Medizinische Klinik V
Bamberg, , Germany
GFO Kliniken Rhein-Berg
Bergisch Gladbach, , Germany
Praxis für Urologie
Berlin, , Germany
Onkologie am Segelfliegerdamm
Berlin, , Germany
Praxis am Volkspark
Berlin, , Germany
Praxis Urologie Köpenick
Berlin, , Germany
Urologische Praxis Berlin
Berlin, , Germany
Vivantes Klinikum am Urban
Berlin, , Germany
Zentrum für urologische Onkologie, Palliativmedizin und allgemeine Urologie
Berlin, , Germany
Urologische Arztpraxis
Bernburg, , Germany
Franziskus Hospital Bielefeld
Bielefeld, , Germany
Centrum für Operative Urologie
Bremen, , Germany
Klinikum Bremen Mitte
Bremen, , Germany
Edia.med MVZ
Chemnitz, , Germany
Gemeinschaftspraxis für Urologie Cottbus
Cottbus, , Germany
Onkologisches Zentrum Donauwörth
Donauwörth, , Germany
Onkozentrum Dresden/Freiberg
Dresden, , Germany
Urologische Gemeinschaftspraxis
Dresden, , Germany
Gemeinschaftspraxis Hämatologie-Onkologie, Dresden
Dresden, , Germany
Fachzentrum für Urologie Eggenfelden
Eggenfelden, , Germany
St. Georg Klinikum
Eisenach, , Germany
Urologische Arztpraxis
Eisleben Lutherstadt, , Germany
Uniklinikum Erlangen
Erlangen, , Germany
Markuskrankenhaus
Frankfurt am Main, , Germany
Gemeinschaftspraxis
Garbsen, , Germany
Universitätsklinikum Gießen und Marburg GmbH
Giessen, , Germany
Universitätsmedizin Göttingen
Göttingen, , Germany
Krankenhaus Martha-Maria Halle-Dölau
Halle, , Germany
Asklepios Klinik Altona
Hamburg, , Germany
Evangelisches Krankenhaus Hamm gGmbH
Hamm, , Germany
Onkologisches Studienzentrum am Raschplatz
Hanover, , Germany
Immunologisch onkologisches MVZ
Hanover, , Germany
Kreiskliniken Herford
Herford, , Germany
Uniklinik Jena
Jena, , Germany
Praxis für Hämatologie, Onkologie und Gerinnung
Kronach, , Germany
Onkologische Schwerpunktpraxis
Kronach, , Germany
Studienzentrum UnterEms
Leer, , Germany
Urologische Arztpraxis
Leipzig, , Germany
Urologische Praxis
Luckenwalde, , Germany
Universitätsklinikum Magdeburg
Magdeburg, , Germany
Uniklinik Marburg
Marburg, , Germany
Praxis für Urologie, Andrologie, Onkologie und medikamentöse Tumortherapie
Markkleeberg, , Germany
Onkologische Praxis Moers
Moers, , Germany
Kliniken Maria Hilf GmbH
Mönchengladbach, , Germany
Facharztpraxis für Hämatologie und Internistische Onkologie
München, , Germany
LMU Urologische Klinik und Poliklinik
München, , Germany
Universitätsklinikum Münster
Münster, , Germany
Praxis Naunhof
Naunhof, , Germany
Urologische Gemeinschaftspraxis
Neunkirchen, , Germany
Praxis für Hämatologie und Internistische Onkologie
Neustadt am Rübenberge, , Germany
Klinikum Nürnberg
Nuremberg, , Germany
MVZ Urologie gGmbH
Nuremberg, , Germany
Sana Klinikum Offenbach GmbH
Offenbach, , Germany
MVZ Kreis Olpe
Olpe, , Germany
Klinikum Osnabrück GmbH
Osnabrück, , Germany
Brüderkrankenhaus St. Josef Paderborn
Paderborn, , Germany
Urologische Praxis
Parchim, , Germany
Urologie
Potsdam, , Germany
Krankenhaus Barmherzige Brüder Regensburg
Regensburg, , Germany
Elblandklinikum Riesa
Riesa, , Germany
MVZ MP Saaletal
Saalfeld, , Germany
Zentrum für Ambulante Onkologie
Schorndorf, , Germany
Klinikum Sindelfingen-Böblingen
Sindelfingen, , Germany
Klinikum Solingen
Solingen, , Germany
Krankenhaus Torgau J. Kentmann gGmbH
Torgau, , Germany
Krankenhaus der Barmherzigen Brüder Trier
Trier, , Germany
Medizinische Studiengesellschaft Nord-West GmbH
Westerstede, , Germany
Praxisgemeinschaft für Onkologie und Urologie
Wilhelmshaven, , Germany
GIM - Gemeinschaftspraxis Innere Medizin
Witten, , Germany
Praxis Urologie Köpenick
Zwickau, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
A-DE-60000-009
Identifier Type: -
Identifier Source: org_study_id